(Q41442103)

30 September 2017

1 reference

title

Magnesium sulfate therapy in certain emergency conditions (English)

1 reference

30 September 2017

0 references

1 reference

Frakes MA

1

1 reference

30 September 2017

Richardson LE 2nd

series ordinal

2

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

American Journal of Emergency Medicine

30 September 2017

published in

1 reference

30 September 2017

volume

15

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

182-187

1 reference

Magnesium and its therapeutic uses: a review

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium: clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

1 reference

7 January 2021

Magnesium metabolism in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Rapid infusion of magnesium sulfate obviates need for intubation in status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Safety and efficacy of magnesium sulfate infusions in children with status asthmaticus.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Serum magnesium levels in asthmatic patients during acute exacerbations of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Intravenous magnesium for acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Adjusting the loading dose of magnesium sulfate for tocolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Intravenous magnesium for acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

A continuing controversy: magnesium sulfate in the treatment of eclamptic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

No, magnesium sulfate should not be used in treating eclamptic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Problems encountered in the treatment of pregnancy-induced hypertension. A point of view

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Phenytoin sodium and magnesium sulphate in the management of eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium sulfate is not an ideal anticonvulsant.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Treatment of torsade de pointes with magnesium sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium therapy for torsades de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Efficacy of magnesium sulfate in the treatment of torsade de pointes.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium therapy in new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Effects of magnesium on the tone of isolated human coronary arteries. Comparison with diltiazem and nitroglycerin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Suppression of exercise-induced angina by magnesium sulfate in patients with variant angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Hemodynamic effects of magnesium sulfate on the normal human heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Effect of magnesium sulfate on cardiovascular hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Suppression of ventricular arrhythmias by magnesium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium and potassium therapy in multifocal atrial tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium deficiency and myocardial infarct size in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Mechanism of myocardial "stunning".

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Myocardial recovery during post-ischaemic reperfusion: Effects of nifedipine, calcium and magnesium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium substitution in acute ischaemic heart syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Beneficial effect of magnesium sulfate in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Intravenous magnesium therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

Magnesium and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2897%2990098-X

7 January 2021

10.1016/S0735-6757(97)90098-X

Identifiers

DOI

1 reference

30 September 2017

1 reference